SXTPW

Quote

Short

News

Articles

Message Board

60 Degrees Pharmaceuticals Inc. Warrant (NASDAQ : SXTPW ) News

News Releases

SXTPW News Releases

June 11, 2026 08:03:00 am

GlobeNewswire

60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement

May 26, 2026 08:02:00 am

GlobeNewswire

60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis

May 15, 2026 08:42:00 am

GlobeNewswire

60 Degrees Pharmaceuticals Announces First Quarter 2026 Results

April 15, 2026 08:02:00 am

GlobeNewswire

60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website

March 31, 2026 07:01:00 am

GlobeNewswire

60 Degrees Pharmaceuticals Announces 2025 Annual Results

March 18, 2026 08:01:00 am

GlobeNewswire

60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract

March 11, 2026 07:24:00 am

GlobeNewswire

60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial

February 02, 2026 08:01:00 am

GlobeNewswire

60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership

January 28, 2026 08:01:00 am

GlobeNewswire

60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use

January 22, 2026 08:01:00 am

GlobeNewswire

60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account